Yun Zhong

Stock Analyst at Wedbush

(0)
# 4841
Out of 5,308 analysts
46
Total ratings
13.04%
Success rate
-28.92%
Average return
Main Sectors:
Top Industries:
23 Stocks
Name Action Price Target Current % Upside Ratings Updated
KROS Keros Therapeutics
Reiterates: Neutral
15 15
11.78 27.33% 1 Apr 1, 2025
PTGX Protagonist Therapeu...
Reiterates: Outperform
70 70
42.47 64.82% 2 Mar 28, 2025
VYGR Voyager Therapeutics
Reiterates: Outperform
n/a
n/a n/a 1 Mar 12, 2025
PASG Passage Bio
Assumes: Outperform
4
0.39 925.64% 2 Nov 29, 2024
MLTX MoonLake
Assumes: Outperform
92 73
35.27 106.97% 1 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
12
2.71 342.8% 1 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 28
8.5 229.41% 2 Feb 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Feb 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 5 Jan 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 16
6.7 138.81% 1 Jan 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
125 160
53.88 196.96% 9 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
48
n/a n/a 3 Dec 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
5.2 573.08% 1 Nov 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Sep 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Sep 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
150 75
n/a n/a 2 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
700
4.84 14362.81% 2 Jul 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
46
8.79 423.32% 1 Jun 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
n/a n/a 1 Jun 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
n/a n/a 1 Jun 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
1.91 423.56% 1 May 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
34
n/a n/a 1 Aug 22, 2018